FDA Adverse Event Malfunction Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 2983268 · Received February 1, 2013

Report

Report Number
3004464228-2013-00080
Event Type
Malfunction
Date Received
February 1, 2013
Date of Event
January 3, 2013
Report Date
January 3, 2013
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K042792
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT RETURNED FOR EVAL. WE ARE UNABLE TO CONFIRM THE CRACK IN THE CANNULA OR TO DETERMINE IF IT COULD HAVE CONTRIBUTED TO THE REPORTED HYPERGLYCEMIA. QUALIFICATION RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. THE OMNIPOD USER GUIDE WARNS, "TEST RESULTS GREATER THAN 250 MG/DL MEAN HIGH BLOOD GLUCOSE (HYPERGLYCEMIA). IF YOU GET RESULTS BELOW 70 MG/DL OR ABOVE 250 MG/DL, BUT DO NOT HAVE SYMPTOMS OF HYPERGLYCEMIA, REPEAT THE TEST. IF YOU HAVE SYMPTOMS OR CONTINUE TO GET RESULTS THAT FALL ABOVE 250 MG/DL, FOLLOW THE TREATMENT ADVICE OF YOUR HEALTHCARE PROVIDER." IT ADVISES, "IF YOUR BLOOD GLUCOSE IS 250 MG/DL OR ABOVE, CHECK FOR KETONES. IF KETONES ARE NOT PRESENT, TAKE A CORRECTION BOLUS AS PRESCRIBED BY YOUR HEALTHCARE PROVIDER. CHECK BLOOD GLUCOSE AGAIN AFTER 2 HOURS. IF BLOOD GLUCOSE LEVELS HAVE NOT DECREASED, TAKE A SECOND BOLUS BY INJECTION, USING A STERILE SYRINGE. IF BLOOD GLUCOSE REMAINS HIGH AFTER ANOTHER 2 HOURS (A TOTAL OF 4 HOURS), REPLACE THE POD. USE A NEW VIAL OF INSULIN TO FILL THE NEW POD."

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT HER BLOOD GLUCOSE MEASURED 336 MG/DL AT 10:57 AM, 299 MG/DL AT 12:04 PM, AND 250 MG/DL AT 5:02 PM. SHE STATED THAT SHE "DID NOT DO ANYTHING BETWEEN THE TIMES." A MANUAL INJECTION OF INSULIN WAS GIVEN, BUT SHE DID NOT REMEMBER THE TIME OR THE DOSAGE. WHEN THE DEVICE WAS REMOVED (TIME NOT REPORTED), THE CANNULA HAD A CRACK ON IT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
45489 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 11200 L31014

Patients

Seq Age Sex Outcome Treatment
1 64 YR